End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.23 CNY | -0.52% |
|
-0.92% | -38.02% |
Jul. 02 | Tranche Update on Hualan Biological Vaccine Inc.'s Equity Buyback Plan announced on June 7, 2024. | CI |
Jun. 07 | Hualan Biological Vaccine to Buy Back Up to 200 Million Yuan Worth of Shares | MT |
Business Summary
Number of employees: 770
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Influenza Vaccine
99.7
%
| 1,818 | 99.6 % | 2,403 | 99.7 % | +32.19% |
Other
0.3
%
| 8 | 0.4 % | 8 | 0.3 % | -3.97% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
99.8
%
| 1,825 | 100.0 % | 2,407 | 99.8 % | +31.84% |
Foreign
0.2
%
| 0 | 0.0 % | 4 | 0.2 % | +1,737.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wen Jue An
CEO | Chief Executive Officer | 35 | 22-03-28 |
Cheng Yu Lü
DFI | Director of Finance/CFO | 43 | 20-05-31 |
Xiao Feng Cui
CTO | Chief Tech/Sci/R&D Officer | 49 | 17-03-31 |
Ruo Wen Pan
BRD | Director/Board Member | 56 | 13-05-31 |
Lun Li
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kang An
CHM | Chairman | 75 | 13-03-31 |
Bei Fan
BRD | Director/Board Member | 52 | 13-03-31 |
Ruo Wen Pan
BRD | Director/Board Member | 56 | 13-05-31 |
De Xin Li
BRD | Director/Board Member | 71 | 20-05-31 |
Xiao Wei Ma
BRD | Director/Board Member | 56 | 13-03-31 |
Chao Yuan Ma
BRD | Director/Board Member | 40 | 20-05-31 |
Wen Qi An
BRD | Director/Board Member | 45 | 20-05-31 |
Yuan Cheng Lou
CHM | Chairman | 40 | 20-05-31 |
Guan Mu Dong
BRD | Director/Board Member | 72 | 20-06-02 |
Wen Jue An
CEO | Chief Executive Officer | 35 | 22-03-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 600,015,000 | 84,102,572 ( 14.02 %) | 0 | 14.02 % |
Company contact information
Hualan Biological Vaccine, Inc.
No. 1, No. 1, Hualan Avenue
453003, Xinxiang
+
http://www.hualanbacterin.com![address Hualan Biological Vaccine Inc.(301207)](https://cdn.zonebourse.com/static/address/136342199.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.02% | 1.43B | |
+6.96% | 101B | |
+8.29% | 42.63B | |
-11.09% | 33.5B | |
+82.32% | 29.77B | |
-11.82% | 16.14B | |
+1.39% | 14.31B | |
-12.13% | 11.55B | |
+176.65% | 10.53B | |
+6.74% | 9.2B |
- Stock Market
- Equities
- 301207 Stock
- Company Hualan Biological Vaccine Inc.